Q4 2015 Holdings
Filed 2016-02-16 | 133 holdings | $2.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | COM | 00287Y109 | $851.5M | 14,373,538 | 37.1% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $730.2M | 20,481,442 | 31.8% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $431.1M | 4,115,083 | 18.8% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $146.7M | 14,217,779 | 6.4% |
| Cerus Corporation(CERS) | COM | 157085101 | $85.7M | 13,553,275 | 3.7% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $20.3M | 8,275,630 | 0.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $9.3M | 505,521 | 0.4% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $6.5M | 100,000 | 0.3% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.1M | 19,475,316 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $1.7M | 37,293,728 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.6M | 50,000 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $1.2M | 6,542,599 | 0.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONDS ADR | 00653A107 | $1.2M | 100,000 | 0.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | COM | 02043Q107 | $1.1M | 11,340 | 0.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $963.0K | 142,000 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $804.0K | 180,582 | 0.0% |
| Incyte Corporation | NOTE 1.25% 11/15/2020 144A | 45337CAL6 | $596.5K | $274,500,000 | 0.0% |
| Incyte Corporation | NOTE 0.375% 11/15/2018 144A | 45337CAK8 | $556.7K | $259,000,000 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $480.8K | 13,659,264 | 0.0% |
| Anacor Pharmaceuticals, Inc. | COM | 032420101 | $474.3K | 4,198,520 | 0.0% |
| Dyax Corp. | COM | 26746E103 | $312.6K | 8,310,017 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $198.3K | 5,462,019 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $153.2K | 3,580,112 | 0.0% |
| Anacor Pharmaceuticals Inc. | NOTE 2.0% 10/15/2021 | 032420AC5 | $152.3K | $42,000,000 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 1.875% 4/23/2017 | 09061GAD3 | $115.2K | $22,379,000 | 0.0% |
| Clovis Oncology Inc. | NOTE 2.5% 9/15/2021 | 189464AB6 | $111.0K | $129,300,000 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $98.6K | 4,865,647 | 0.0% |
| Gilead Sciences Inc. | NOTE 1.625% 5/1/2016 | 375558AP8 | $93.5K | $20,944,000 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $93.4K | 2,955,074 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $84.2K | 6,747,332 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $77.6K | 2,907,784 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $60.4K | 4,452,445 | 0.0% |
| Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | $59.3K | $51,583,000 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $57.2K | 1,262,382 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $53.8K | 6,554,967 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $48.1K | 850,739 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $40.2K | 3,241,783 | 0.0% |
| Sangamo BioSciences, Inc.(SGMO) | COM | 800677106 | $37.0K | 4,055,876 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $33.5K | 1,931,057 | 0.0% |
| Intra-Cellular Therapies, Inc.(ITCIEUR) | COM | 46116X101 | $32.8K | 609,166 | 0.0% |
| Medivation, Inc. | COM | 58501N101 | $31.9K | 659,752 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $26.7K | 4,350,808 | 0.0% |
| Gilead Sciences, Inc.(GILD) | COM | 375558103 | $25.3K | 249,995 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | COM | 88322Q108 | $23.9K | 2,003,991 | 0.0% |
| Exelixis, Inc. | NOTE 4.25% 8/15/2019 | 30161QAC8 | $23.3K | $20,000,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $23.2K | 369,276 | 0.0% |
| aTyr Pharma Inc.(LIFEUSD) | COM | 002120103 | $23.0K | 2,335,125 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | COM | 00448Q201 | $21.6K | 2,000,000 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $21.6K | 6,983,107 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $19.9K | 250,251 | 0.0% |